FDA Approves First Treatment For Cerebrotendinous Xanthomatosis, A Rare Lipid Storage Disease
SILVER SPRING, Md., Feb. 21, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli ...
Scientists urge caution after a carcinogen is detected in water in fire-stricken areas
While residents in the Palisades and Eaton fire areas can use tap water for some limited purposes, the detection of a ...